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The six day subrenal capsule (SRC) assay was developed by Bogden et al. (1978) as an in vivo xenograft system that could be used to investigate the effects of cytotoxic agents on a variety of human tumours from xenografts established in nude mice, and on primary surgical explants of human tumours (Bogden et al., 1981) . Initially, the technique involved the use of nude mice, but later it was shown that it was possible to use normal immunocompetent mice (Bogden et al., 1979) . This, of course, made the SRC very cost effective, and the short time frame of the assay was seen as a major advantage when compared to the time required to grow xenografts subcutaneously in nude mice.
Gastric adenocarcinoma is the fourth most common malignancy in the UK. In general, chemotherapy has made little impact on the disease, and combination chemotherapy regimens will usually produce objective tumour regression in only 30-45% of patients (Cunningham et al., 1984; Schein et al., 1982) . Nevertheless, those patients who respond to chemotherapy undoubtedly benefit in terms of survival, but the price is unnecessary toxicity in those who do not respond (Cunningham et al., 1985) . We, therefore, felt that this was a suitable tumour in which to study a predictive chemotherapy system such as the SRC. Preliminary information from Bogden's group suggested that it should be feasible to grow primary surgical explants from gastric cancer (Griffen et al., 1983) , and we therefore initiated a study to investigate the possible role of the SRC as a chemopredictive test in gastric cancer.
The technique used was similar to that described by Bogden et al. (1978) patients were operated on in GRI, therefore transportation time for specimens was minimised where a sample_ 1 cm3 was removed. This was dissected into four 0.5ncm3 pieces and returned to the tissue culture medium for transfer to the laboratories. In the laboratory the tissue was prepared for transplantation by dissection into pieces 1 mm3 for which procedure a template placed under a glass petri dish was used as a guide. A specimen was retained for histological analysis. The mice (C57BL/6 x DBA/2) F, hybrid, age 14-20 weeks were weighed, anaesthetised with diethyl ether and an incision was made laterally in the region of the left kidney, which was subsequently exteriorised. An incision was made in the renal capsule (Ziegler iridectomy knife with a 4mm blade) and the tumour introduced using a trochar (supplied by MacCarthy's Surgical Ltd, Dagenham, UK). Two perpendicular diameters of tumour were measured in situ using a Zeiss Stereoscopic microscope with a micrometer scale such that 1 micrometer unit (MU) was equivalent to 0.1 mm. After measurement the kidney was carefully re-sited in the abdomen, and the incision was closed using a stapler gun. Each control group had 5-8 mice and each treatment group had 4-6 mice. All surgery was carried out by one operator (DC) with technical assistance from DFSMcM.
Six days later, the mice were killed, re-weighed and the tumour re-measured in situ. An evaluable assay was one in which the mean increase of the sum of the two perpendicular diameters was 0.5MU (which is the same criterion as Bogden et al., 1978) . Thereafter, the tumour bearing kidney was removed and placed in formol saline. Chemotherapy was given on days 1, 3, 5 as outlined in Table I . The drugs tested were those employed in our current regimen for advanced gastric cancer.
Sections, prepared from the mouse kidney and implanted tumour, were stained with haematoxylin and eosin. They were examined by one pathologist D. CUNNINGHAM et al. In addition to the tissue from surgical explants, tumour was also obtained from a human xenograft and an animal allograft for transplantation. These were Wils tumour, which is a human lung adenocarcinoma established in nude mice and Walker 256 which is a rodent sarcoma grown in Wistar rats.
Specimens of gastric adenocarcinoma were obtained from 17 patients. Sixteen were from the primary tumour and one was from a lymph node metastasis. The specimens retained for histological analysis all showed tumour. From the 17 gastric tumours a total of 418 xenografts were transplanted within the minimal possible time. Fourteen of the 17 tumours gave evaluable assays in the control groups with a mean increase in the sum of the tumour diameters of 4.1 MU (range 1.6-10.5).
However, when the xenografts were examined histologically tumour cells were present in only 26 (6%) and the remaining xenografts consisted of fibrous tissue and a lymphocytic infiltrate. It should be emphasised that although a small number of xenografts contained tumour, this consisted of a few acini or single tumour cells as shown in Figure  1 . The extent to which the xenografts were infiltrated by lymphocytes was significantly influenced by the administration of cytotoxic drugs. Xenografts from control groups invariably had a pronounced lymphocytic infiltrate compared to treated groups (Figure 2A, B) . These findings were reflected in the Inflammation Score which is represented in Figure 3 . Moreover, there was a significantly positive correlation (P<0.001) between the Inflammation Score and the increase in size of the xenografts (Spearman's Rank Correlation). In the case of one tumour, rather than giving the treatment groups chemotherapy, the animals were sacrificed on days 1, 3 and 5 and the tumours were examined histologically. This revealed, as might be expected, a progressive increase in the amount of lymphocytic infiltrate over the period of the assay. Also, there was no tumour seen in the transplanted Figure 4A . Histology confirmed that the increase in the size of xenografts was due to tumour-( Figure 4B ). There was persistence of the lymphocytic infiltrate but in view of the marked tumour growth, the contribution of this to the increase in xenograft size was probably negligible.
Although assessment of a cytotoxic agent's activity against a given tumour. Thus, for tumour derived from primary surgical explants, histological validation of the assay is essential. Levi et al. (1984) have developed the SRC assay to include a histological scoring system which encompasses both the extent of tumour necrosis and the amount of lymphocytic infiltration. This appears to be better and more sensitive than tumour measurement alone, but obviously has the disadvantage of making the SRC assay more complex, and time consuming to perform. Our experience with the transplantation of human and animal tumour xenografts under the SRC has been limited to two tumour types. Nevertheless, we have been impressed with the reproducibility of the growth of these tumours within the SRC system. Indeed, the scale of growth was such that routine extensive histological analysis should not be essential, and is unlikely to add to simple tumour measurement. Moreover, in this context the 'size artefact' related to lymphocytic infiltration will be less relevant.
In conclusion, the growth of primary surgical explants from gastric cancer under the SRC of mice has, in our experience, not been possible. Also, in general, histological validation of surgical explants grown under SRC is advisable because of the size artefact related to lymphocytic infiltration.
